2024 ATAWM and CCSNMMI Michigan Road Show:
Bold Advanced Medical Future – Personalized Healthcare with Advanced Molecular Imaging
Saturday, November 9, 2024, 8:00am – 3:00pm Central
Register Now to attend in person at BAMF. There is NO cost to attend the in person meeting, but you MUST register in advance.

BAMF Health
Doug Meijer Medical Innovation Building
109 Michigan St NW, Grand Rapids, MI 49525
Room: 7th Floor Conference Room
Parking: Complimentary parking is available at the garage located opposite the Medical Innovation building.

In our continued efforts to bring our members what they ask for, the Continuing Education Committee is taking you to the future of advanced molecular imaging.

Join us on Saturday, November 9th for presentations LIVE in Grand Rapids, Michigan and hear from leading nuclear medicine professionals from across the country. We are offering CME for Physicians and VOICE credits for Technologists.  You can stay as little or as long as you want.

Program Schedule: (Please note that times below are for the Eastern Time Zone.)

7 – 8:00am – Breakfast, Visit with Vendors

8-8:30am – Myocardial Perfusion PET Imaging: A Cardiologist’s Perspective, David Cameron, MD, Corewell Health

8:30-9am – The Scope of the Novel Clinical Trial Investigating O-15 Water PET in Coronary Artery Disease: Background and Scientific Evidence, Jens Sorensen, MD, Uppsala University Hospital

9-9:15am – Break

9:15-9:45am – Imaging Cancer through the Stroma- FAPI PET/CT, a Novel Tracer in Oncology, Sherly Mosessian, PhD, SOFIE

9:45-10:15am – Targeted Molecular Imaging: The Oncologist’s Perspective, Sreenivasa Chandana, MD, PhD, The Cancer & Hematology Centers

10:15-10:30am – Break

10:30-11am – Nuclear Medicine as the Pillar of Theranostics, Harshad Kulkarni, MD, BAMF Health

11-11:30am – NuMeMentor: Tomorrow’s Professionals, Fernando Anleu, CNMT, BAMF Health and Nichole Ozinga, CNMT, ARRT(N), NMTCB(PET), NMTCB(CT), Corewell Health

11:30am – 12pm – Bridging the Gap: How Can Community Practices Offer Clinical Trials as an Advanced Care Option?, Deepak Behera, MD, PhD, Adaptive Research

12-12:30pm – PSMA PET Imaging: A Urologist’s Perspective, Brian Lane, MD, PhD, Corewell Health

12:30pm – 2pm – Lunch, Tour and Visit with Vendors

2-2:30pm – PYL4301 Phase 4 Clinical Study (MIRROR) Assessing Piflufolastat F 18 PET Utility in Favorable Intermediate Risk Prostate Cancer: Background, Objectives, Study Design, and Implications, Roman Bilyk, MD, Lantheus

2:30-3pm – Novel Clinical Trial (Clarify) Investigating Cu-64 SAR-bis-PSMA: Background and Scientific Evidence, Erica Sztangret, Clarity Pharmaceuticals